Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 451.5 SEK 1.23% Market Closed
Market Cap: 14.2B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Xvivo Perfusion AB
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xvivo Perfusion AB
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
Xvivo Perfusion AB
STO:XVIVO
Cash Taxes Paid
kr11.1m
CAGR 3-Years
127%
CAGR 5-Years
38%
CAGR 10-Years
11%
O
OssDsign AB
STO:OSSD
Cash Taxes Paid
kr677k
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Cash Taxes Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Cash Taxes Paid
€11.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Cash Taxes Paid
kr17.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xvivo Perfusion AB
Glance View

Market Cap
14.2B SEK
Industry
Health Care

Xvivo Perfusion AB is a medical technology company. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 92 full-time employees. The company went IPO on 2012-10-08. The firm operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The firm markets its products in Europe, Asia, Middle East, and North & South America.

XVIVO Intrinsic Value
251.13 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Xvivo Perfusion AB's Cash Taxes Paid?
Cash Taxes Paid
11.1m SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Cash Taxes Paid amounts to 11.1m SEK.

What is Xvivo Perfusion AB's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
11%

Over the last year, the Cash Taxes Paid growth was 608%. The average annual Cash Taxes Paid growth rates for Xvivo Perfusion AB have been 127% over the past three years , 38% over the past five years , and 11% over the past ten years .

Back to Top